Risperidone Mylan 1mg orodispersible Tablets Malta - Engels - Medicines Authority

risperidone mylan 1mg orodispersible tablets

mylan pharmaceuticals limited damastown industrial park mulhuddart dublin15 dublin, ireland - risperidone - orodispersible tablet - risperidone 1 mg - psycholeptics

Risperidone Mylan 2mg orodispersible Tablets Malta - Engels - Medicines Authority

risperidone mylan 2mg orodispersible tablets

mylan pharmaceuticals limited damastown industrial park mulhuddart dublin15 dublin, ireland - risperidone - orodispersible tablet - risperidone 2 mg - psycholeptics

Risperidone Mylan 3mg orodispersible Tablets Malta - Engels - Medicines Authority

risperidone mylan 3mg orodispersible tablets

mylan pharmaceuticals limited damastown industrial park mulhuddart dublin15 dublin, ireland - risperidone - orodispersible tablet - risperidone 3 mg - psycholeptics

RISPERIDONE tablet, film coated Verenigde Staten - Engels - NLM (National Library of Medicine)

risperidone tablet, film coated

wockhardt limited - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 0.25 mg - pregnancy category c. the teratogenic potential of risperidone was studied in three segment ii studies in sprague- dawley and wistar rats (0.63 to 10 mg/kg or 0.4 to 6 times the maximum recommended human dose [mrhd] on a mg/m2 basis) and in one segment ii study in new zealand rabbits (0.31 to 5 mg/kg or 0.4 to 6 times the mrhd on a mg/m2 basis). the incidence of malformations was not increased compared to control in offspring of rats or rabbits given 0.4 to 6 times the mrhd on a mg/m2 basis. in three reproductive studies in rats (two segment iii and a multigenerational study), there was an increase in pup deaths during the first 4 days of lactation at doses of 0.16 to 5 mg/kg or 0.1 to 3 times the mrhd on a mg/m2 basis. it is not known whether these deaths were due to a direct effect on the fetuses or pups or to effects on the dams. there was no no-effect dose for increased rat pup mortality. in one segment iii study, there was an increase in stillborn rat pups at a dose of 2.5 mg/kg or 1.5 times the

RISPERIDONE tablet Verenigde Staten - Engels - NLM (National Library of Medicine)

risperidone tablet

tya pharmaceuticals - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 4 mg - adults risperidone tablets are indicated for the acute and maintenance treatment of schizophrenia .  [see ] clinical studies (14.1) adolescents risperidone tablets are indicated for the treatment of schizophrenia in adolescents aged 13–17 years [see ]. clinical studies (14.1) monotherapy - adults and pediatrics risperidone tablets are indicated for the short-term treatment of acute manic or mixed episodes associated with bipolar i disorder in adults .  [see ] clinical studies (14.2) combination therapy – adults the combination of risperidone tablets with lithium or valproate is indicated for the short-term treatment of acute manic or mixed episodes associated with bipolar i disorder . [see ] clinical studies (1

Risperidone-DRLA Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

risperidone-drla

dr reddy's new zealand limited - risperidone 0.5mg - film coated tablet - 0.5 mg - active: risperidone 0.5mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose opadry brown 03b56980 pregelatinised maize starch purified talc purified water sodium laurilsulfate - risperidone tablets are indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. · risperidone tablets also alleviate affective symptoms (such as depression, guiltfeelings, anxiety) associated with schizophrenia.

Risperidone-DRLA Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

risperidone-drla

dr reddy's new zealand limited - risperidone 1mg - film coated tablet - 1 mg - active: risperidone 1mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose opadry white oy-58900 purified talc sodium laurilsulfate starch - risperidone tablets are indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. · risperidone tablets also alleviate affective symptoms (such as depression, guiltfeelings, anxiety) associated with schizophrenia.

Risperidone-DRLA Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

risperidone-drla

dr reddy's new zealand limited - risperidone 2mg - film coated tablet - 2 mg - active: risperidone 2mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose opadry orange 03b53509 purified talc sodium laurilsulfate starch - risperidone tablets are indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. · risperidone tablets also alleviate affective symptoms (such as depression, guiltfeelings, anxiety) associated with schizophrenia.

Risperidone-DRLA Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

risperidone-drla

dr reddy's new zealand limited - risperidone 3mg - film coated tablet - 3 mg - active: risperidone 3mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 03b52209 purified talc sodium laurilsulfate starch - risperidone tablets are indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. · risperidone tablets also alleviate affective symptoms (such as depression, guiltfeelings, anxiety) associated with schizophrenia.

Risperidone-DRLA Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

risperidone-drla

dr reddy's new zealand limited - risperidone 4mg - film coated tablet - 4 mg - active: risperidone 4mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose opadry green 03b51293 purified talc sodium laurilsulfate starch - risperidone tablets are indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. · risperidone tablets also alleviate affective symptoms (such as depression, guiltfeelings, anxiety) associated with schizophrenia.